Reflecting on PHUSE 2024

Feb 13, 2025
Reflecting on PHUSE 2024

Wrapping up an exciting 2024 conference season and gearing up for an eventful 2025 for Staburo GmbH! 

Last November, we had the privilege of attending the Phuse EU Connect 2024 in beautiful Strasbourg, a flagship event for statistical programmers in drug development and healthcare. With over 700 attendees from 36 countries, it was the largest in-person connect yet – buzzing with insightful sessions, engaging discussions, and wonderful networking opportunities. 

Our colleagues Jannis Ströbele and Angelika Böhm represented Staburo, diving into a rich program of plenary and parallel sessions, workshops, and a lively poster session. They also made the most of the social events, from speed networking on Sunday to the grand gala dinner on Monday – truly an event to remember! 

As we look back on the many conferences we attended in 2024, we’re thrilled to share that our 2025 agenda is already packed! We can’t wait to reconnect and share insights at events like DAGStat, PSI conference, BIO International Convention, APF, BVMA symposium and many more! 

We’re looking forward to connecting with many of you at upcoming events! 

More Articles

7th Staburo Health Data Science Summit 

7th Staburo Health Data Science Summit 

The 7th Staburo Health Data Science Summit brought together experts from the pharmaceutical and life sciences industries to explore the evolving role of biomarkers and data science in advancing precision medicine.  With contributions from leading organizations,...

read more
Staburo @ ISCB/GMDS Conference 2026

Staburo @ ISCB/GMDS Conference 2026

Staburo Team Selected to Present at ISCB/GMDS Conference 2026 We are pleased to share that Maria Stark, Senior Data Scientist, and the team representing Staburo in the GMDS Biostatistics Competition have been selected to present their work at the upcoming ISCB/GMDS...

read more
Biomarkers at Staburo

Biomarkers at Staburo

In 2024 at Staburo was about building momentum in the area Biomarkers. Deepening our engagement in the PSI Biomarker SIG, strengthening collaborations, and developing the ideas that would later become deliverables. In 2025, we developed and released ShadowVIMP, an R...

read more